Zydus gets USFDA final approval for Valacyclovir tablets
Ahmedabad: Zydus Pharmaceuticals USA Inc has received the final approval from the USFDA to market Valacyclovir Tablets USP in strengths of 500 mg and 1 gm.
The drug is indicated for the treatment of cold sores (herpes labialis), genital herpes, chickenpox and herpes zoster (shingles).
It will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad.
The group now has more than 180 approvals and has so far filed over 310 ANDAs since the commencement of the filing process in FY 2003-04.
Zydus Pharmaceuticals Inc is a wholly-owned subsidiary of Cadila Healthcare Ltd.